Alan Kay
Impact in
- Hepatology top 0.5%
- Hepatitis C virus research
- Hepatitis Viruses Studies and Epidemiology
- Epidemiology top 2%
- Hepatitis B Virus Studies
- Liver Disease Diagnosis and Treatment
Papers in
- Epidemiology 40
- Hepatitis B Virus Studies 40
- Liver Disease Diagnosis and Treatment 9
- Hepatology 32
- Hepatitis C virus research 31
- Hepatitis Viruses Studies and Epidemiology 10
- Co-authors
- Fabien Zoulim (17 shared papers)Francis Galibert (7 shared papers)Elisabeth Mandart (6 shared papers)Christian Trépo (10 shared papers)Isabelle Chemin (8 shared papers)Christian Trépo (9 shared papers)Bernard Mandrand (3 shared papers)Lucyna Cova (7 shared papers)
- Journals
- Journal of General Virology (5 papers)Virology (5 papers)Journal of Virology (5 papers)Journal of Medical Virology (3 papers)Journal of Clinical Microbiology (3 papers)
- Partner nations
- FranceBrazilUnited States
In The Last Decade
Alan Kay
50 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 61
- Hepatology 1.2k
- Epidemiology 1.6k
- Virology 113
- Infectious Diseases 347
- Animal Science and Zoology 169
Countries citing papers authored by Alan Kay
This map shows the geographic impact of Alan Kay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Kay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Kay more than expected).
Fields of papers citing papers by Alan Kay
This network shows the impact of papers produced by Alan Kay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Kay. The network helps show where Alan Kay may publish in the future.
Co-authors
The 25 scholars most cited alongside Alan Kay, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1984 | 261 | |
| 2 | 2007 | 214 | |
| 3 | 2012 | 144 | |
| 4 | 2001 | 141 | |
| 5 | 1985 | 88 | |
| 6 | 2004 | 73 | |
| 7 | 2011 | 58 | |
| 8 | 1991 | 57 | |
| 9 | 1993 | 53 | |
| 10 | 2008 | 52 | |
| 11 | 2002 | 51 | |
| 12 | 2001 | 42 | |
| 13 | 1990 | 39 | |
| 14 | 2008 | 38 | |
| 15 | 2000 | 37 | |
| 16 | 1973 | 36 | |
| 17 | 2006 | 34 | |
| 18 | 1992 | 31 | |
| 19 | 2013 | 30 | |
| 20 | 1993 | 27 |
About Alan Kay
Alan Kay is a scholar working on Epidemiology, Hepatology, Molecular Biology, Infectious Diseases and Animal Science and Zoology, having authored 51 papers that have together received 1.8k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (40 papers), Hepatitis C virus research (31 papers), Hepatitis Viruses Studies and Epidemiology (10 papers), Liver Disease Diagnosis and Treatment (9 papers), Viral gastroenteritis research and epidemiology (7 papers), Animal Virus Infections Studies (6 papers), HIV Research and Treatment (5 papers) and Bacteriophages and microbial interactions (5 papers). The work is most often cited by research in Hepatology (1.2k citations), Epidemiology (1.6k citations), Virology (113 citations), Infectious Diseases (347 citations) and Animal Science and Zoology (169 citations). Alan Kay has collaborated with scholars based in France, Brazil and United States. Frequent co-authors include Fabien Zoulim, Francis Galibert, Elisabeth Mandart, Christian Trépo, Isabelle Chemin, Christian Trépo, Bernard Mandrand, Lucyna Cova, C. Trépo and M. Grunberg‐Manago. Their work appears in journals such as Journal of General Virology, Virology, Journal of Virology, Journal of Medical Virology and Journal of Clinical Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.